Literature DB >> 22267443

[Summary of the article: Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011; 365: 1557-1559].

Ewa Szczerba1.   

Abstract

Entities:  

Year:  2012        PMID： 22267443

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  9 in total

Review 1.  Promise of factor Xa inhibition in acute coronary syndromes.

Authors:  Leong Lee; Derek Chew
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

2.  Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients.

Authors:  Bruria Hirsh Raccah; Amihai Rottenstreich; Netanel Zacks; Mordechai Muszkat; Ilan Matok; Amichai Perlman; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

4.  Efficacy and safety of rivaroxaban thromboprophylaxis after arthroplasty of the hip or knee: retrospective cohort study.

Authors:  V Loganathan; A Hua; S Patel; C Gibbons; M P Vizcaychipi
Journal:  Ann R Coll Surg Engl       Date:  2016-09       Impact factor: 1.891

Review 5.  Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation.

Authors:  Athanasios J Manolis; Leonidas E Poulimenos
Journal:  J Atr Fibrillation       Date:  2013-02-12

6.  Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Authors:  Wolfgang Mueck; Anthonie W A Lensing; Giancarlo Agnelli; Hervé Decousus; Paolo Prandoni; Frank Misselwitz
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

7.  Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients.

Authors:  Bruria Hirsh Raccah; Amihai Rottenstreich; Netanel Zacks; Ilan Matok; Haim D Danenberg; Arthur Pollak; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2019-05       Impact factor: 2.300

8.  The Characteristics and Clinical Outcomes of Direct Oral Anticoagulantsin Patients with Atrial Fibrillation and Chronic Kidney Disease: From the Database of A Single-Center Registry.

Authors:  Takao Sato; Yoshifusa Aizawa; Hitoshi Kitazawa; Masaaki Okabe
Journal:  J Atr Fibrillation       Date:  2020-08-31

9.  How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH).

Authors:  Alessandro Prior; Pietro Fiaschi; Corrado Iaccarino; Roberto Stefini; Denise Battaglini; Alberto Balestrino; Pasquale Anania; Enrico Prior; Gianluigi Zona
Journal:  BMC Neurol       Date:  2021-03-03       Impact factor: 2.474
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.